Clinical Trial

Precision Biomarkers to Detect Brain Injury in Active-Duty United States Special Operations Forces With Repeated Blast Exposure

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a 4-year, longitudinal study of 100 active-duty Navy SEALs. The goal of the study is to determine whether repeated blast exposure affects SEAL brain health and to develop an initial diagnostic testing protocol that detects repeated blast brain injury.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-12.
Status change: Not Yet Recruiting → Recruiting 2025-10-30
Trial Details
NCT Number NCT07131475
Lead Sponsor Massachusetts General Hospital
Collaborators: University of South Florida, Navy SEAL Foundation, National Institutes of Health (NIH), Uniformed Services University of the Health Sciences
Conditions Blast Injury
Enrollment 100 participants
Start Date 2025-10-14
Primary Completion 2029-04-30 (estimated)
Study Completion 2029-08-31 (estimated)
Updated on ClinicalTrials.gov 2025-10-31